Emilio Chiosi
Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
12-months prospective Pentraxin-3 and metabolomic evaluation in multiple sclerosis patients treated with glatiramer acetate.
Journal: Journal of neuroimmunology
Published: June 03, 2020
Chlorogenic acid activates ERK1/2 and inhibits proliferation of osteosarcoma cells.
Journal: Journal of cellular physiology
Published: July 12, 2019
Forskolin improves sensitivity to doxorubicin of triple negative breast cancer cells via Protein Kinase A-mediated ERK1/2 inhibition.
Journal: Biochemical pharmacology
Published: February 12, 2018
The Natural cAMP Elevating Compound Forskolin in Cancer Therapy: Is It Time?
Journal: Journal of cellular physiology
Published: September 11, 2016
Inorganic Phosphate Prevents Erk1/2 and Stat3 Activation and Improves Sensitivity to Doxorubicin of MDA-MB-231 Breast Cancer Cells.
Journal: Molecules (Basel, Switzerland)
Published: July 07, 2015
Targeting protein kinase A in cancer therapy: an update.
Journal: EXCLI journal
Published: January 01, 2014
Effects of milk feeding, frequency and concentration on weaning and buffalo (Bubalus bubalis) calf growth, health and behaviour.
Journal: Tropical animal health and production
Published: May 03, 2013
cAMP Elevation Down-Regulates β3 Integrin and Focal Adhesion Kinase and Inhibits Leptin-Induced Migration of MDA-MB-231 Breast Cancer Cells.
Journal: BioResearch open access
Published: March 22, 2013
Integrating leptin and cAMP signalling pathways in triple-negative breast cancer cells.
Journal: Frontiers in bioscience (Landmark edition)
Published: January 02, 2013
Last Updated: 09/26/2026